carmustine has been researched along with Acute Coronary Syndrome in 1 studies
Carmustine: A cell-cycle phase nonspecific alkylating antineoplastic agent. It is used in the treatment of brain tumors and various other malignant neoplasms. (From Martindale, The Extra Pharmacopoeia, 30th ed, p462) This substance may reasonably be anticipated to be a carcinogen according to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (From Merck Index, 11th ed)
carmustine : A member of the class of N-nitrosoureas that is 1,3-bis(2-chloroethyl)urea in which one of the nitrogens is substituted by a nitroso group.
Acute Coronary Syndrome: An episode of MYOCARDIAL ISCHEMIA that generally lasts longer than a transient anginal episode that ultimately may lead to MYOCARDIAL INFARCTION.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Waibel Pachinger, C | 1 |
| Rosselet, A | 1 |
| Berthouzoz, S | 1 |
| Luthi, F | 1 |
| Ketterer, N | 1 |
1 other study available for carmustine and Acute Coronary Syndrome
| Article | Year |
|---|---|
Acute coronary syndrome upon receiving carmustine infusion before autologous stem-cell transplantation.
Topics: Acute Coronary Syndrome; Antineoplastic Agents, Alkylating; Carmustine; Central Nervous System Neopl | 2012 |